| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.029 | 0.3 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.029 | 0.3 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.4 |